Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00858390 · ClinicalTrials.gov registry record · NA

Nutritional Status and Enteral Absorption Capability After Brain Death

A NA study, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
36
Enrollment target

NCT00858390 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 36 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00858390, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target

Study Summary

The investigators propose to assess 36 donors' nutritional status using accepted parameters (prealbumin, resting energy expenditure); to assess nutrient intestinal absorption through 13Curacil breath tests; and to evaluate serum concentrations of IL-6 and TNFalpha to determine if continuing or initiating enteral feeding and nutritional supplementation is effective in restoring or maintaining nutritional parameters.

Interventions

  • DIETARY_SUPPLEMENT enteral feeding with Oxepa® and Glutasolve®

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2009-02
Est. Completion 2013-12
Phase NA

What the Registry Record Tells You About NCT00858390

The ClinicalTrials.gov registry entry for NCT00858390 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which enteral feeding with Oxepa® and Glutasolve® is the first listed.

NCT00858390 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00858390 about?

NCT00858390 is a clinical study titled "Nutritional Status and Enteral Absorption Capability After Brain Death". The investigators propose to assess 36 donors' nutritional status using accepted parameters (prealbumin, resting energy expenditure); to assess nutrient intestinal absorption through 13Curacil breath tests; and to evaluate serum concentrations of IL-6 and TNFalpha to determine if continuing or initi...

What is the current status of trial NCT00858390?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2009-02. Estimated completion is 2013-12.

What interventions are being tested in trial NCT00858390?

The interventions under investigation include: enteral feeding with Oxepa® and Glutasolve® (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00858390?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.